Search Results - "Korc, Murray"

Refine Results
  1. 1

    Pancreatic cancer–associated stroma production by Korc, Murray, M.D

    Published in The American journal of surgery (01-10-2007)
    “…Abstract One of the defining features of pancreatic ductal adenocarcinoma (PDAC) is the presence of extensive desmoplasia. The desmoplastic stroma consists of…”
    Get full text
    Journal Article
  2. 2

    Pancreatic cancer-associated diabetes is an "exosomopathy" by Korc, Murray

    Published in Clinical cancer research (01-04-2015)
    “…Diabetes may be a consequence of pancreatic cancer, preceding cancer diagnosis. The underlying mechanism is the release of exosomes delivering adrenomedullin…”
    Get full text
    Journal Article
  3. 3

    Pancreatic cancer: Stroma and its current and emerging targeted therapies by Kota, Janaiah, Hancock, Julie, Kwon, Jason, Korc, Murray

    Published in Cancer letters (10-04-2017)
    “…Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal human malignancies with a 5-year survival rate of 8%. Dense, fibrotic stroma…”
    Get full text
    Journal Article
  4. 4

    A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer by Lai, Xianyin, Wang, Mu, McElyea, Samantha Deitz, Sherman, Stuart, House, Michael, Korc, Murray

    Published in Cancer letters (01-05-2017)
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that often presents clinically at an advanced stage and that may be confused with…”
    Get full text
    Journal Article
  5. 5

    Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells by Liu, Fang, Korc, Murray

    Published in Molecular cancer therapeutics (01-10-2012)
    “…Aberrant activation of Cyclin D-Cdk4/6 signaling pathway is commonly found in pancreatic ductal adenocarcinoma (PDAC). Here, we show that PD-0332991, a highly…”
    Get full text
    Journal Article
  6. 6

    Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer by Andersen, Dana K, Korc, Murray, Petersen, Gloria M, Eibl, Guido, Li, Donghui, Rickels, Michael R, Chari, Suresh T, Abbruzzese, James L

    Published in Diabetes (New York, N.Y.) (01-05-2017)
    “…The relationships between diabetes and pancreatic ductal adenocarcinoma (PDAC) are complex. Longstanding type 2 diabetes (T2DM) is a risk factor for pancreatic…”
    Get full text
    Journal Article
  7. 7

    Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes by Joshi, Gayatri K, Deitz-McElyea, Samantha, Liyanage, Thakshila, Lawrence, Katie, Mali, Sonali, Sardar, Rajesh, Korc, Murray

    Published in ACS nano (24-11-2015)
    “…MicroRNAs are short noncoding RNAs consisting of 18–25 nucleotides that target specific mRNA moieties for translational repression or degradation, thereby…”
    Get full text
    Journal Article
  8. 8

    Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells by Enane, Francis O., Saunthararajah, Yogen, Korc, Murray

    Published in Cell death & disease (06-09-2018)
    “…Chemotherapeutic drugs have a common intent to activate apoptosis in tumor cells. However, master regulators of apoptosis (e.g., p53, p16/CDKN2A) are…”
    Get full text
    Journal Article
  9. 9

    Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment by Lin, Chien-Chi, Korc, Murray

    Published in Cancer letters (01-11-2018)
    “…Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer mortality in the United States, with a 5-year survival of ∼8%. PDAC is…”
    Get full text
    Journal Article
  10. 10

    The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy by Principe, Daniel R, Underwood, Patrick W, Korc, Murray, Trevino, Jose G, Munshi, Hidayatullah G, Rana, Ajay

    Published in Frontiers in oncology (15-07-2021)
    “…Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with a median survival time of 10-12 months. Clinically, these poor outcomes are attributed to…”
    Get full text
    Journal Article
  11. 11

    Driver mutations: A roadmap for getting close and personal in pancreatic cancer by Korc, Murray

    Published in Cancer biology & therapy (15-09-2010)
    “…Commentary to: Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM) Hannah…”
    Get full text
    Journal Article
  12. 12

    Highly Specific Plasmonic Biosensors for Ultrasensitive MicroRNA Detection in Plasma from Pancreatic Cancer Patients by Joshi, Gayatri K, Deitz-McElyea, Samantha, Johnson, Merrell, Mali, Sonali, Korc, Murray, Sardar, Rajesh

    Published in Nano letters (10-12-2014)
    “…MicroRNAs (miRs) are small noncoding RNAs that regulate mRNA stability and/or translation. Because of their release into the circulation and their remarkable…”
    Get full text
    Journal Article
  13. 13

    Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma by Craven, Kelly E, Gore, Jesse, Korc, Murray

    Published in Cancer letters (10-10-2016)
    “…Highlights • Pancreatic ductal adenocarcinoma (PDAC) is hypovascular. • Vascular endothelial growth factor A (gene: VEGFA) (VEGF-A) is overexpressed in PDAC. •…”
    Get full text
    Journal Article
  14. 14

    Tobacco and alcohol as risk factors for pancreatic cancer by Korc, Murray, Jeon, Christie Y., Edderkaoui, Mouad, Pandol, Stephen J., Petrov, Maxim S.

    “…Pancreatic cancer is projected to become the leading cause of cancer deaths by 2050. The risk for pancreatic cancer may be reduced by up to 27% by modifying…”
    Get full text
    Journal Article
  15. 15

    A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile by Cote, Gregory A, Gore, A Jesse, McElyea, Samantha D, Heathers, Laura E, Xu, Huiping, Sherman, Stuart, Korc, Murray

    Published in The American journal of gastroenterology (01-12-2014)
    “…Accurate peripheral markers for the diagnosis of pancreatic ductal adenocarcinoma (PDAC) are lacking. We measured the differential expression of select…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia by SEELEY, E. Scott, CARRIERE, Catherine, GOETZE, Tobias, LONGNECKER, Daniel S, KORC, Murray

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Primary cilia have been proposed to participate in the modulation of growth factor signaling pathways. In this study, we determined that ciliogenesis is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness by NEUPANE, Divas, KORC, Murray

    Published in Clinical cancer research (01-12-2008)
    “…Purpose: The purpose of the present study was to investigate the potential role of 14-3-3σ in pancreatic ductal adenocarcinoma (PDAC). Experimental Design:…”
    Get full text
    Journal Article
  20. 20